Dual-site cGMP manufacturing
For supply chain continuity, we manufacture Gibco Amphotericin B at two separate facilities located in Grand Island, NY and Scotland, UK. Both sites are compliant with cGMP manufacturing requirements, are certified to the ISO 13485 standard, and are registered with the FDA as medical device manufacturers.
Agent | Amphotericin B |
Product Line | Fungizone® |
Quantity | 50mL |
Reagent Type | Anti-Mycotic |
Shipping Condition | Dry Ice |
Validated Application | Prevention of Cell Culture Contamination |
Form | Liquid |
CATALOG | UNIT SIZE |
---|---|
15290026 | 50 mL |
15290018 | 20 mL |